Jeffery Bleich, MD
Dr. Bleich is the founder and CEO of Pulson, Inc., developer ofCounterpace, a sensor-based guidance system designed to optimize heart and brain blood flow during aerobic exercise, enhancing physical performance, health, safety, experience, and recovery. After serving as an Executive in Residence at Prospect Venture Partners, a healthcare-dedicated VC firm; and working in product design at IDEO, an internationally renowned design firm; he founded Baxano (NASDAQ: BAXS) to provide less invasive, more effective surgical treatment options for spinal stenosis. Dr. Bleich currently practices anesthesiology at Stanford Medical Center and is fellowship trained in multidisciplinary pain management.